ArticleJournal of health economics and outcomes researchPublished
Matching-Adjusted Indirect Comparison of the Efficacy and Safety of Erdafitinib vs Enfortumab Vedotin in Patients with Locally Advanced Metastatic Urothelial Carcinoma
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Journal of health economics and outcomes research
- Published
- Topic
- Clinical care
- Subject terms
- Indirect Treatment Comparison; Matching-adjusted Indirect Comparison; Erdafitinib; Enfortumab Vedotin; Locally Advanced Unresectable Metastatic Urothelial Carcinoma
- PubMed ID
- 39267886
- PubMed Central ID
- PMC11392482
- Open access
- Yes, open
- Added to directory
- Source checked